Stocktoria
RECURSION PHARMACEUTICALS, INC. RXRX
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-04-16
RECURSION PHARMACEUTICALS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| ARK Investment Management LLC | 41,337,632 | $151.7M | 7.83% |
| BlackRock Finance, Inc. | 17,310,162 | $129.8M | 3.28% |
| TWO SIGMA INVESTMENTS, LP | 3,353,658 | $12.3M | 0.63% |
| CITADEL ADVISORS LLC | 2,540,478 | $9.3M | 0.48% |
| MILLENNIUM MANAGEMENT LLC | 1,834,762 | $6.7M | 0.35% |
| AQR CAPITAL MANAGEMENT LLC | 422,087 | $1.5M | 0.08% |
| D. E. Shaw & Co., Inc. | 37,914 | $139,144 | 0.01% |
| Bridgewater Associates, LP | 37,667 | $138,238 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.